Fasoracetam Uses, Dosage, Side Effects and more
Fasoracetam is under investigation in clinical trial NCT03609619 (PART B: Efficacy and Safety of AEVI-001 in Children and Adolescents With ADHD and Without Mglur Mutations).
| Attribute | Details |
|---|---|
| Trade Name | Fasoracetam |
| Generic | Fasoracetam |
| Fasoracetam Other Names | Fasoracetam |
| Type | |
| Formula | C10H16N2O2 |
| Weight | Average: 196.25 Monoisotopic: 196.121177763 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
